Bloomberg Law
Dec. 19, 2022, 5:34 PMUpdated: Dec. 19, 2022, 9:00 PM

Pfizer Defeats Suit Challenging Diverse Student Fellowships (1)

Patrick Dorrian
Patrick Dorrian

A nationwide group representing White and Asian American applicants lacked standing to challenge a Pfizer Inc. fellowship designed to build a diverse workforce, including at the leadership level.

Do No Harm’s members include health-care professionals, students, patients, and policy-makers “who want to protect healthcare from radical, divisive, and discriminatory ideologies.” That includes “the rise in explicit racial discrimination in graduate and postgraduate medical programs,” according to the organization.

Pfizer’s “Breakthrough Fellowship” is one such program, the organization alleged in a Sept. 15 lawsuit. It sought a preliminary injunction barring the pharmaceutical maker from going forward with its 2023 application ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.